Schill Johan, Olsson Hans
Department of Psychiatry, House N1, Jönköping County Hospital, Region Jönköping County, SE- 55185 Jönköping, Sweden.
Department of Psychiatry, Ryhov County Hospital, Jönköping, Sweden.
Ther Adv Psychopharmacol. 2016 Dec;6(6):349-354. doi: 10.1177/2045125316657796. Epub 2016 Aug 8.
The objective of this study was to investigate the concordance in attitudes of psychiatrists towards the doses of antipsychotics given to stable outpatients with schizophrenia and to examine the psychiatrists' estimates of equally potent doses of haloperidol and olanzapine.
We asked all 22 doctors serving at the psychiatry department of Jönköping County Hospital if they considered the combined dose of antipsychotics for 20 individual patients to be 'low', 'medium' or 'high'. We also asked each doctor to state the dose of haloperidol that they considered to be clinically equivalent to 20 mg/day of olanzapine.
The inter-rater reliability (Krippendorff's alpha (α)) was 0.50, and the mean estimated dose haloperidol considered clinically equivalent to 20 mg/day of olanzapine was 4.45 mg/day.
The inter-rater reliability (Krippendorff's α) was low, suggesting lack of agreement. The dose of antipsychotics given to a patient might thus be more influenced by which doctor they meet than the severity of the disease. The respondents in this study considered a mean dose of 4.45 mg/day of haloperidol to be clinically equivalent to 20 mg/day of olanzapine. This is a considerably lower dose than was determined by an international consensus study of antipsychotic dosing, and more in line with the available PET studies measuring central dopamine receptor blockage of optimal clinical doses.
本研究的目的是调查精神科医生对给予稳定期精神分裂症门诊患者抗精神病药物剂量的态度一致性,并检查精神科医生对氟哌啶醇和奥氮平等效剂量的估计。
我们询问了延雪平郡医院精神科的所有22名医生,他们是否认为20名个体患者的抗精神病药物联合剂量为“低”、“中”或“高”。我们还要求每位医生说出他们认为在临床上等同于20毫克/天奥氮平的氟哌啶醇剂量。
评分者间信度(克里彭多夫α系数)为0.50,认为在临床上等同于20毫克/天奥氮平的氟哌啶醇平均估计剂量为4.45毫克/天。
评分者间信度(克里彭多夫α系数)较低,表明缺乏一致性。因此,给予患者的抗精神病药物剂量可能更多地受到他们遇到的医生的影响,而不是疾病的严重程度。本研究中的受访者认为,4.45毫克/天的氟哌啶醇平均剂量在临床上等同于20毫克/天的奥氮平。这一剂量远低于抗精神病药物剂量的国际共识研究所确定的剂量,更符合现有的测量最佳临床剂量的中枢多巴胺受体阻断情况的PET研究结果。